阿司匹林延迟早产前子痫高风险妊娠的早产:来自亚洲随机临床试验的证据
该研究为亚洲多中心阶梯楔形整群随机试验的二次分析,纳入早孕期筛查后早产前子痫高风险(调整风险≥1/100)孕妇,低剂量阿司匹林从<16周用至36周。结果显示阿司匹林与早期早产风险降低42%相关(aRR 0.577,95%CI 0.380-0.852),并显著延迟早产时间。
要点
- 早产前子痫高风险孕妇使用低剂量阿司匹林与早期早产风险降低42%相关。
- 阿司匹林显著延迟早期早产,24周时延迟3.63周,37周时仅延迟0.25周。
- 阿司匹林对子痫前期孕妇的医源性早期早产风险降低60%(aRR 0.398)。
核心结论
- 早期给予阿司匹林可有效降低早产前子痫高风险女性的早期早产风险。
- 研究结果支持阿司匹林通过延迟分娩时间来预防早产的假说,对原本会更早分娩者影响更大。
研究设计与样本
- 研究为多中心阶梯楔形整群随机试验的二次分析,涵盖亚洲10个地区18个产科/诊断单位,时间为2019年8月1日至2022年2月28日。
- 随机试验中42 897/48 647名女性接受早产前子痫筛查,排除后非干预阶段纳入10 294名、干预阶段纳入27 965名女性。
- 4688名早产前子痫高风险女性中,2909名(62.05%)在试验中接受了阿司匹林。
主要发现
- 阿司匹林与早期早产风险降低42%相关(aRR 0.577,95%CI 0.380-0.852),晚期早产率呈显著上升趋势(趋势检验P<0.01)。
- 医源性早产和小于胎龄儿妊娠中观察到类似结果。
- 子痫前期妊娠中,阿司匹林与医源性早期早产风险降低60%相关(aRR 0.398,95%CI 0.192-0.788),但对医源性晚期早产无显著影响。
- 阿司匹林显著延迟早期早产,孕周每增加一周效应减少0.26周(95%可信区间-0.40至-0.05);24周时延迟3.63周,37周时延迟0.25周。
关键数值与推荐
- 早产前子痫高风险定义为基于贝叶斯定理的三联检测调整风险≥1/100。
- 低剂量阿司匹林从<16周使用至36周妊娠。
- 早期早产定义为24+0至31+6周妊娠,晚期早产定义为32+0至36+6周。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To investigate the impact of aspirin administration on the incidence of preterm birth, according to the type of delivery and gestational age at preterm birth, and to examine the hypothesis that aspirin delays preterm delivery. METHODS: This was a secondary analysis of a multicenter stepped-wedge cluster randomized trial of a first-trimester screen-and-prevent strategy for preterm pre-eclampsia (PE), which included 18 maternity/diagnostic units in 10 regions across Asia between 1 August 2019 and 28 February 2022. Women deemed to be at high risk for preterm PE according to a Bayes' theorem-based triple test, i.e. those with an adjusted risk for preterm PE of ≥ 1 in 100, received low-dose aspirin from < 16 weeks until 36 weeks' gestation. Outcome measures were the incidence of early preterm birth (24 + 0 to 31 + 6 weeks' gestation) and late preterm birth (32 + 0 to 36 + 6 weeks). The treatment effect of aspirin on the rate of preterm birth, stratified by gestational age at birth, type of delivery and presence of pregnancy complications, was estimated by computing the relative risks (RR) between the aspirin and non-aspirin groups with their 95% CIs. A shift model was designed to evaluate the effect of aspirin on preterm birth, based on the hypothesis that aspirin delays a preterm birth to a more advanced gestational age. RESULTS: In the randomized trial, 42 897/48 647 women accepted screening for preterm PE. Following exclusions, 10 294 and 27 965 women were included in the non-intervention and intervention phases, respectively. Of the 4688 women at high risk for preterm PE, 2909 (62.05%) received aspirin in the trial. Aspirin was associated with a 42% reduction in the risk of early preterm birth (adjusted relative risk (aRR), 0.577 (95% CI, 0.380-0.852)), and there was a significant upward trend in the rate of late preterm birth accordingly (test for trend, P < 0.01). Similar findings were observed for iatrogenic preterm birth and pregnancies with a small-for-gestational-age neonate. Additionally, aspirin was associated with a 60% reduction in the risk of iatrogenic early preterm birth in pregnancies with PE (aRR, 0.398 (95% CI, 0.192-0.788)). However, aspirin did not have a significant effect on iatrogenic late preterm birth in pregnancies with PE. Aspirin significantly delayed early preterm birth, with the effect decreasing by 0.26 (95% credibility interval, -0.40 to -0.05) weeks for each week of advancing gestation. At 24 weeks, aspirin delayed delivery by 3.63 weeks, while at 37 weeks, the delay was only 0.25 weeks. CONCLUSIONS: This secondary explanatory analysis found that early administration of aspirin could effectively reduce the risk of early preterm birth in women at high risk for preterm PE. While the reasons for preterm birth are often multifactorial, this study provides greater insight into the relationship between aspirin and different types of preterm birth at different gestational ages. Our findings support the hypothesis that aspirin helps to prevent preterm birth by delaying the timing of delivery, with a greater impact observed for deliveries that would have occurred at an earlier gestational age had aspirin not been administered. © 2025 The Author(s). Ultrasound in Obstetrics & Gynecology published by John Wiley & Sons Ltd on behalf of International Society of Ultrasound in Obstetrics and Gynecology.
引用
- Leung HHY, Papastefanou I, Chen Y, et al. Aspirin delays preterm birth in pregnancies at high risk for preterm pre-eclampsia: evidence from randomized clinical trial in Asia. Ultrasound Obstet Gynecol. 2025. PMID: 40454801. doi:10.1002/uog.29255
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。